Sinopharm Tech Holdings Balans Gezondheid
Financiële gezondheid criteriumcontroles 0/6
Sinopharm Tech Holdings has a total shareholder equity of HK$-182.5M and total debt of HK$10.0M, which brings its debt-to-equity ratio to -5.5%. Its total assets and total liabilities are HK$46.2M and HK$228.7M respectively.
Belangrijke informatie
-5.5%
Verhouding schuld/eigen vermogen
HK$10.00m
Schuld
| Rente dekkingsratio | n/a |
| Contant | HK$8.51m |
| Aandelen | -HK$182.51m |
| Totaal verplichtingen | HK$228.74m |
| Totaal activa | HK$46.23m |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Is Sinopharm Tech Holdings Limited's (HKG:8156) Shareholder Ownership Skewed Towards Insiders?
Feb 02
How Much Did Sinopharm Tech Holdings'(HKG:8156) Shareholders Earn From Share Price Movements Over The Last Five Years?
Dec 29
How Should Investors Feel About Sinopharm Tech Holdings' (HKG:8156) CEO Remuneration?
Nov 24Analyse van de financiële positie
Kortlopende schulden: 8156 has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Langlopende schulden: 8156 has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 8156 has negative shareholder equity, which is a more serious situation than a high debt level.
Schuld verminderen: 8156's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: Insufficient data to determine if 8156 has enough cash runway based on its current free cash flow.
Voorspelling contante baan: Insufficient data to determine if 8156 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.